Published in Proc Natl Acad Sci U S A on December 15, 1991
Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci U S A (2003) 12.17
A single dose of doxorubicin-functionalized bow-tie dendrimer cures mice bearing C-26 colon carcinomas. Proc Natl Acad Sci U S A (2006) 2.55
Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys J (1994) 2.55
Targeted pharmaceutical nanocarriers for cancer therapy and imaging. AAPS J (2007) 2.38
Range and magnitude of the steric pressure between bilayers containing phospholipids with covalently attached poly(ethylene glycol). Biophys J (1995) 2.35
Protein adsorption on surfaces with grafted polymers: a theoretical approach. Biophys J (1997) 2.26
Brain drug delivery of small molecules using immunoliposomes. Proc Natl Acad Sci U S A (1996) 1.91
Measurements of attractive forces between proteins and end-grafted poly(ethylene glycol) chains. Proc Natl Acad Sci U S A (1997) 1.89
Multifunctional and stimuli-sensitive pharmaceutical nanocarriers. Eur J Pharm Biopharm (2008) 1.78
Structure and phase behavior of lipid suspensions containing phospholipids with covalently attached poly(ethylene glycol). Biophys J (1995) 1.75
Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst (2009) 1.73
Silencing disease genes in the laboratory and the clinic. J Pathol (2011) 1.72
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest (1998) 1.72
Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J Control Release (2006) 1.70
Ultrasound radiation force enables targeted deposition of model drug carriers loaded on microbubbles. J Control Release (2005) 1.68
Blood-brain barrier transport of therapeutics via receptor-mediation. Pharm Res (2007) 1.54
Lipid membrane expansion and micelle formation by polymer-grafted lipids: scaling with polymer length studied by spin-label electron spin resonance. Biophys J (2001) 1.40
Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomedicine (2007) 1.37
A coarse-grained model for polyethylene oxide and polyethylene glycol: conformation and hydrodynamics. J Phys Chem B (2009) 1.37
Nanoparticle clearance is governed by Th1/Th2 immunity and strain background. J Clin Invest (2013) 1.36
Tumor-targeted nanomedicines: enhanced antitumor efficacy in vivo of doxorubicin-loaded, long-circulating liposomes modified with cancer-specific monoclonal antibody. Clin Cancer Res (2009) 1.35
Supramolecular materials via polymerization of mesophases of hydrated amphiphiles. Chem Rev (2002) 1.33
Nanotheranostics - application and further development of nanomedicine strategies for advanced theranostics. Theranostics (2014) 1.29
Liposomes as nanomedical devices. Int J Nanomedicine (2015) 1.29
Best practices in cancer nanotechnology: perspective from NCI nanotechnology alliance. Clin Cancer Res (2012) 1.24
Multi-stage delivery nano-particle systems for therapeutic applications. Biochim Biophys Acta (2010) 1.23
Gold nanoparticles: From nanomedicine to nanosensing. Nanotechnol Sci Appl (2008) 1.21
Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc Natl Acad Sci U S A (1995) 1.18
Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies. Eur J Nucl Med Mol Imaging (2006) 1.17
Brain-specific expression of an exogenous gene after i.v. administration. Proc Natl Acad Sci U S A (2001) 1.15
Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur J Pharm Sci (2007) 1.14
Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes. Int J Pharm (2007) 1.14
Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice. Antimicrob Agents Chemother (1995) 1.14
Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release. ACS Nano (2012) 1.12
Gadolinium-based contrast agents for magnetic resonance cancer imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2012) 1.12
A novel peptide enhances therapeutic efficacy of liposomal anti-cancer drugs in mice models of human lung cancer. PLoS One (2009) 1.10
A phenomenological one-parameter equation of state for osmotic pressures of PEG and other neutral flexible polymers in good solvents. J Phys Chem B (2009) 1.09
Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal Doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia (2004) 1.08
Shaping cancer nanomedicine: the effect of particle shape on the in vivo journey of nanoparticles. Nanomedicine (Lond) (2014) 1.07
Tumour uptake of doxorubicin in polyethylene glycol-coated liposomes and therapeutic effect against a xenografted human pancreatic carcinoma. Br J Cancer (1997) 1.07
Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. J Control Release (2013) 1.06
Tumor targeting using liposomal antineoplastic drugs. Int J Nanomedicine (2008) 1.06
Drug transport to brain with targeted liposomes. NeuroRx (2005) 1.05
Immunoconjugates and long circulating systems: origins, current state of the art and future directions. Adv Drug Deliv Rev (2012) 1.05
Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors. J Biol Chem (2009) 1.05
Stimulus-responsive macromolecules and nanoparticles for cancer drug delivery. Nanomedicine (Lond) (2010) 1.04
Challenges in development of targeted liposomal therapeutics. AAPS J (2012) 1.03
Tumor-specific antibody-mediated targeted delivery of Doxil reduces the manifestation of auricular erythema side effect in mice. Int J Pharm (2008) 1.03
Effect of repetitive administration of Doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clin Cancer Res (2005) 1.01
The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods. Adv Healthc Mater (2015) 1.01
Extravasation and transcytosis of liposomes in Kaposi's sarcoma-like dermal lesions of transgenic mice bearing the HIV tat gene. Am J Pathol (1993) 1.00
Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy. J Chromatogr B Analyt Technol Biomed Life Sci (2004) 0.99
Exchange of monooleoylphosphatidylcholine as monomer and micelle with membranes containing poly(ethylene glycol)-lipid. Biophys J (1997) 0.98
Impact of hapten presentation on antibody binding at lipid membrane interfaces. Biophys J (2008) 0.97
Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy. J Biomed Biotechnol (2010) 0.97
Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies. Br J Cancer (1996) 0.97
Design considerations for nanotherapeutics in oncology. Nanomedicine (2015) 0.96
Light-sensitive lipid-based nanoparticles for drug delivery: design principles and future considerations for biological applications. Mol Membr Biol (2010) 0.96
Efficacy and safety of Stealth liposomal doxorubicin in AIDS-related Kaposi's sarcoma. The International SL-DOX Study Group. Br J Cancer (1996) 0.96
Long-circulating 15 nm micelles based on amphiphilic 3-helix peptide-PEG conjugates. ACS Nano (2012) 0.96
A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis. PLoS One (2012) 0.94
Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci (2003) 0.94
An overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stains. Ann Biomed Eng (2011) 0.93
Cancer cell invasion: treatment and monitoring opportunities in nanomedicine. Adv Drug Deliv Rev (2011) 0.93
Injectable lipid emulsions-advancements, opportunities and challenges. AAPS PharmSciTech (2010) 0.93
Evaluation of doxorubicin-loaded 3-helix micelles as nanocarriers. Biomacromolecules (2013) 0.92
Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob Agents Chemother (1995) 0.92
Cationic liposome-nucleic acid complexes for gene delivery and gene silencing. New J Chem (2014) 0.92
Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes. ACS Nano (2014) 0.92
Secretory phospholipase A₂ responsive liposomes. J Pharm Sci (2011) 0.92
Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem (2013) 0.91
Optimization of PEGylation conditions for BSA nanoparticles using response surface methodology. AAPS PharmSciTech (2010) 0.91
The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment. Expert Opin Drug Deliv (2010) 0.91
Liposomal Antioxidants for Protection against Oxidant-Induced Damage. J Toxicol (2011) 0.90
Tumor microvascular permeability is a key determinant for antivascular effects of doxorubicin encapsulated in a temperature sensitive liposome. Int J Hyperthermia (2008) 0.90
Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery. Int J Nanomedicine (2012) 0.89
Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound. PLoS One (2012) 0.89
Cholesterol transport from liposomal delivery vehicles. Biomaterials (2007) 0.89
Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles. Biomaterials (2014) 0.89
Structure and interactive properties of highly fluorinated phospholipid bilayers. Biophys J (1996) 0.88
Multimodal in vivo imaging exposes the voyage of nanoparticles in tumor microcirculation. ACS Nano (2013) 0.88
Solubilization of poorly soluble PDT agent, meso-tetraphenylporphin, in plain or immunotargeted PEG-PE micelles results in dramatically improved cancer cell killing in vitro. Eur J Pharm Biopharm (2005) 0.88
Loading of hydrophobic materials into polymer particles: implications for fluorescent nanosensors and drug delivery. J Am Chem Soc (2005) 0.88
Doxorubicin encapsulated in stealth liposomes conferred with light-triggered drug release. Biomaterials (2015) 0.87
Phospho-ibuprofen (MDC-917) suppresses breast cancer growth: an effect controlled by the thioredoxin system. Breast Cancer Res (2012) 0.87
Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies. Br J Cancer (2000) 0.86
Phase I and pharmacokinetic study of pegylated liposomal CKD-602 in patients with advanced malignancies. Clin Cancer Res (2009) 0.86
Tuftsin augments antitumor efficacy of liposomized etoposide against fibrosarcoma in Swiss albino mice. Mol Med (2007) 0.86
Application of poly(ethylene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomedicine (2012) 0.86
Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy. Int J Radiat Oncol Biol Phys (2015) 0.86
Phototriggerable liposomes: current research and future perspectives. Pharmaceutics (2013) 0.86
The effect of internalizing human single chain antibody fragment on liposome targeting to epithelioid and sarcomatoid mesothelioma. Biomaterials (2011) 0.86
Development of the novel PEG-PE-based polymer for the reversible attachment of specific ligands to liposomes: synthesis and in vitro characterization. Bioconjug Chem (2011) 0.85
Pegylated liposomal doxorubicin: appraisal of its current role in the management of epithelial ovarian cancer. Cancer Manag Res (2011) 0.85
Targeting the neurovascular unit for treatment of neurological disorders. Pharmacol Ther (2010) 0.85
Microfluidic system for facilitated quantification of nanoparticle accumulation to cells under laminar flow. Ann Biomed Eng (2012) 0.85
Interaction of cationic colloids at the surface of J774 cells: a kinetic analysis. Biophys J (2000) 0.85
Increased liposome extravasation in selected tissues: effect of substance P. Proc Natl Acad Sci U S A (1996) 0.85
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett (1990) 5.14
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
Transport of molecules across tumor vasculature. Cancer Metastasis Rev (1987) 3.67
Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. Biochim Biophys Acta (1979) 3.20
Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci U S A (1988) 2.74
Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis (1985) 2.64
Liposomes for the sustained drug release in vivo. Biochim Biophys Acta (1990) 2.16
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
The effect of particle size and charge on the clearance rates of liposomes and liposome encapsulated drugs. Biochem Biophys Res Commun (1975) 1.78
Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochim Biophys Acta (1991) 1.75
Large unilamellar liposomes with low uptake into the reticuloendothelial system. FEBS Lett (1987) 1.71
Uptake of liposomes by cultured mouse bone marrow macrophages: influence of liposome composition and size. Biochim Biophys Acta (1991) 1.55
Stability of small unilamellar liposomes in serum and clearance from the circulation: the effect of the phospholipid and cholesterol components. Life Sci (1982) 1.40
Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. Biochim Biophys Acta (1989) 1.40
Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles. Science (1983) 1.38
Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections. Eur J Cancer Clin Oncol (1988) 1.38
Pharmacokinetics and tissue distribution of doxorubicin encapsulated in stable liposomes with long circulation times. J Natl Cancer Inst (1989) 1.23
Stability of lipid vesicles in tissues of the mouse: a gamma-ray perturbed angular correlation study. Proc Natl Acad Sci U S A (1979) 1.22
Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface. Proc Natl Acad Sci U S A (1988) 1.13
Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: biodistribution and imaging studies. Cancer Res (1990) 1.10
Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol (1986) 1.10
Hepatic uptake and degradation of unilamellar sphingomyelin/cholesterol liposomes: a kinetic study. Proc Natl Acad Sci U S A (1980) 1.10
Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol (1982) 1.08
Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta (1981) 1.06
Physicochemical characterization of large unilamellar phospholipid vesicles prepared by reverse-phase evaporation. Biochim Biophys Acta (1983) 1.06
Liposomal protection of adriamycin-induced cardiotoxicity in mice. Cancer Res (1980) 1.02
Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophages. Biochim Biophys Acta (1988) 1.02
Effect of liposome size and drug release properties on pharmacokinetics of encapsulated drug in rats. J Pharmacol Exp Ther (1983) 1.01
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
In vitro and in vivo studies with adriamycin liposomes. Biochem Biophys Res Commun (1979) 0.98
Antitumor activity of liposome-encapsulated doxorubicin in advanced breast cancer: phase II study. J Natl Cancer Inst (1990) 0.98
Effects of liposome-entrapped doxorubicin on liver metastases of mouse colon carcinomas 26 and 38. J Natl Cancer Inst (1987) 0.98
Liposomes containing lipid A: a potent nontoxic adjuvant for a human malaria sporozoite vaccine. Immunol Lett (1990) 0.97
Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice. Br J Cancer (1980) 0.95
Tissue distribution of liposomes exhibiting long half-lives in the circulation after intravenous injection. Biochim Biophys Acta (1985) 0.95
Successful imaging of human cancer with indium-111-labeled phospholipid vesicles. Cancer (1988) 0.93
Targeting of liposomes to tumor cells in vivo. Ann N Y Acad Sci (1987) 0.92
Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta (1990) 0.92
125I labelled inulin: a convenient marker for deposition of liposomal contents in vivo. Biochem Biophys Res Commun (1984) 0.89
Liposomes containing colloidal gold are a useful probe of liposome-cell interactions. Biochim Biophys Acta (1983) 0.89
Light microscopic localization of silver-enhanced liposome-entrapped colloidal gold in mouse tissues. Biochim Biophys Acta (1991) 0.88
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta (1985) 0.88
Recent advances in sustained release of antineoplastic drugs using liposomes which avoid uptake into the reticuloendothelial system. Proc West Pharmacol Soc (1989) 0.85
Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat Med (1999) 4.93
A conformational and structure-activity relationship study of cytotoxic 3,5-bis(arylidene)-4-piperidones and related N-acryloyl analogues. J Med Chem (2001) 4.82
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators. N Engl J Med (1998) 4.22
Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim Biophys Acta (1991) 4.16
Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res (1994) 3.54
Oral gene delivery with chitosan--DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med (1999) 3.36
Analysis of Gag-specific cytotoxic T lymphocytes in simian immunodeficiency virus-infected rhesus monkeys by cell staining with a tetrameric major histocompatibility complex class I-peptide complex. J Exp Med (1998) 3.35
Sterically stabilized liposomes. Biochim Biophys Acta (1992) 3.10
Modulation of interaction forces between bilayers exposing short-chained ethylene oxide headgroups. Biophys J (1994) 2.55
Improved DNA: liposome complexes for increased systemic delivery and gene expression. Nat Biotechnol (1997) 2.52
Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med (1995) 2.52
pH-dependent perforation of macrophage phagosomes by listeriolysin O from Listeria monocytogenes. J Exp Med (1997) 2.26
Mucosal AIDS vaccine reduces disease and viral load in gut reservoir and blood after mucosal infection of macaques. Nat Med (2001) 2.10
Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times. Biochim Biophys Acta (1991) 2.08
Persistent recognition of autologous virus by high-avidity CD8 T cells in chronic, progressive human immunodeficiency virus type 1 infection. J Virol (2004) 2.07
Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol (2000) 2.00
Skin toxic effects of polyethylene glycol-coated liposomal doxorubicin. Arch Dermatol (2000) 1.98
Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies. J Clin Oncol (1995) 1.77
Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med (1996) 1.77
Cytotoxic activities of Mannich bases of chalcones and related compounds. J Med Chem (1998) 1.74
Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. Biochim Biophys Acta (1980) 1.66
Predictors of in-hospital mortality after DC catheter ablation of atrioventricular junction. Results of a prospective, international, multicenter study. Circulation (1991) 1.64
Reversal of deteriorated fractal behavior of heart rate variability by beta-blocker therapy in patients with advanced congestive heart failure. J Cardiovasc Electrophysiol (2001) 1.62
Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice. Cancer Res (1992) 1.62
Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin Cancer Res (2000) 1.59
Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim Biophys Acta (1992) 1.58
Serum-induced leakage of liposome contents. Biochim Biophys Acta (1980) 1.55
Identification of a novel cytokine, ML-1, and its expression in subjects with asthma. J Immunol (2001) 1.55
Doxorubicin in sterically stabilized liposomes. Nature (1996) 1.54
Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther (2000) 1.54
Acute pericarditis resulting from an endocardial active fixation screw-in atrial lead. Pacing Clin Electrophysiol (1994) 1.52
Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol (2000) 1.52
Cellular electrophoretic mobility and the mitotic cycle. J Gen Physiol (1966) 1.51
Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma. Cancer (2000) 1.51
Identification and mutational analysis of the immunodominant IgE binding epitopes of the major peanut allergen Ara h 2. Arch Biochem Biophys (1997) 1.47
Insertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time. FEBS Lett (1996) 1.46
Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. J Immunol (1994) 1.44
Ventricular lead transection and atrial lead damage in a young softball player shortly after the insertion of a permanent pacemaker. Pacing Clin Electrophysiol (1992) 1.42
Closed chest catheter desiccation of the atrioventricular junction using radiofrequency energy--a new method of catheter ablation. J Am Coll Cardiol (1987) 1.41
Anti-tyrosinase-related protein-2 immune response in vitiligo patients and melanoma patients receiving active-specific immunotherapy. J Invest Dermatol (1998) 1.41
Biochemical and structural analysis of the IgE binding sites on ara h1, an abundant and highly allergenic peanut protein. J Biol Chem (1998) 1.40
Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege. J Immunol (1998) 1.40
Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection. J Virol (2001) 1.40
Quantitative measurement of intraorganelle pH in the endosomal-lysosomal pathway in neurons by using ratiometric imaging with pyranine. Proc Natl Acad Sci U S A (1995) 1.39
Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res (1992) 1.38
Ligand-targeted liposomal anticancer drugs. Prog Lipid Res (2003) 1.37
Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy. J Neurosurg (1995) 1.36
Incorporation of lipid vesicles by mammalian cells provides a potential method for modifying cell behaviour. Nature (1974) 1.33
Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys (1996) 1.32
Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol (1983) 1.30
Liposomes with prolonged blood circulation and selective localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis (1993) 1.30
Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures. Biochim Biophys Acta (1995) 1.29
The effect of neuraminidase on the phagocytic process in human monocytes. Lab Invest (1966) 1.27
In vitro and in vivo targeting of immunoliposomal doxorubicin to human B-cell lymphoma. Cancer Res (1998) 1.27
The human mast cell: functions in physiology and disease. Front Biosci (2001) 1.25
Photoinitiated ion movements in bilayer membranes containing magnesium octaethylporphyrin. Biophys J (1986) 1.25
Mucosal IFN-gamma gene transfer inhibits pulmonary allergic responses in mice. J Immunol (1996) 1.25
Induction of mucosal homing virus-specific CD8(+) T lymphocytes by attenuated simian immunodeficiency virus. J Virol (2000) 1.25
Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol (2001) 1.22
Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim Biophys Acta (1992) 1.22
Selective delivery of doxorubicin to patients with breast carcinoma metastases by stealth liposomes. Cancer (1999) 1.21
Chemotherapeutic CNS prophylaxis and neuropsychologic change in children with acute lymphoblastic leukemia: a prospective study. J Pediatr Psychol (2001) 1.17
Therapy of human ovarian carcinoma xenografts using doxorubicin encapsulated in sterically stabilized liposomes. Cancer (1993) 1.16
Efficacy of gentamicin or ceftazidime entrapped in liposomes with prolonged blood circulation and enhanced localization in Klebsiella pneumoniae-infected lung tissue. J Infect Dis (1995) 1.16
Immunotargeting of liposomes to activated vascular endothelial cells: a strategy for site-selective delivery in the cardiovascular system. Proc Natl Acad Sci U S A (1997) 1.14
Genome-wide linkage analyses of total serum IgE using variance components analysis in asthmatic families. Genet Epidemiol (2001) 1.14
Induction of pulmonary allergic responses by antigen-specific Th2 cells. J Immunol (1998) 1.14
An IL13 coding region variant is associated with a high total serum IgE level and atopic dermatitis in the German multicenter atopy study (MAS-90). J Allergy Clin Immunol (2000) 1.13
Phosphoinositide 3-kinase is required for aldosterone-regulated sodium reabsorption. Am J Physiol (1999) 1.13
New detachable poly(ethylene glycol) conjugates: cysteine-cleavable lipopolymers regenerating natural phospholipid, diacyl phosphatidylethanolamine. Bioconjug Chem (1999) 1.13
Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. Cancer Res (1976) 1.12
Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol (2012) 1.11
Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes. Int J Cancer (1992) 1.11
A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs. FEBS Lett (1999) 1.11
Studies of synthetic peptide analogs of the amphipathic helix. Effect of charged amino acid residue topography on lipid affinity. J Biol Chem (1980) 1.10
In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta (2001) 1.10
A molecular model for vesicle formation. Biochim Biophys Acta (1982) 1.09
Metastatic inefficiency in mice bearing B16 melanomas. Br J Cancer (1982) 1.09
Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells. Biochim Biophys Acta (2001) 1.09
Successful treatment of aconitine induced life threatening ventricular tachyarrhythmia with amiodarone. Heart (2000) 1.08
Characterization, toxicity and therapeutic efficacy of adriamycin encapsulated in liposomes. Eur J Cancer Clin Oncol (1982) 1.08
Increased ouabain-sensitive 86Rb+ uptake and sodium and potassium ion-activated adenosine triphosphatase activity in transformed cell lines. J Biol Chem (1975) 1.08
Cellular uptake of cyclic AMP captured within phospholipid vesicles and effect on cell-growth behaviour. Biochim Biophys Acta (1974) 1.08
Liposome preparation and size characterization. Methods Enzymol (1989) 1.07
Quantitation of tumorigenic disseminating and arrested cancer cells. Br J Cancer (1984) 1.07
Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution. J Pharmacol Exp Ther (1984) 1.07
Cutting edge: altered pulmonary eosinophilic inflammation in mice deficient for Clara cell secretory 10-kDa protein. J Immunol (2001) 1.06
Lipid mixing during membrane aggregation and fusion: why fusion assays disagree. Biochemistry (1987) 1.06
Understanding cytotoxic T-lymphocyte escape during simian immunodeficiency virus infection. Immunol Rev (2001) 1.06
Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes. J Pharm Sci (1996) 1.05
Size analysis of phospholipid vesicle preparations. Science (1982) 1.05
Lifetime exposure to cigarette smoking and the development of adult-onset atopic dermatitis. Br J Dermatol (2011) 1.05
Allergic airway hyperreactivity increases the risk for corneal allograft rejection. Am J Transplant (2009) 1.04